A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor (Q34403975)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor |
scientific article |
Statements
1 reference
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor (English)
1 reference
1 reference
Philip M Murphy
1 reference
Sandra Anaya-O'Brien
1 reference
Stefania Pittaluga
1 reference
Qian Liu
1 reference
Daniel Velez
1 reference
Lizbeeth Lopez
1 reference
Jean Ulrick
1 reference
Nana Kwatemaa
1 reference
Judy Starling
1 reference
Thomas A Fleisher
1 reference
Debra A Long Priel
1 reference
Melissa A Merideth
1 reference
Robert L Giuntoli
1 reference
Moses O Evbuomwan
1 reference
Patricia Littel
1 reference
Martha M Marquesen
1 reference
Dianne Hilligoss
1 reference
Rosamma DeCastro
1 reference
George J Grimes
1 reference
Samuel T Hwang
1 reference
Pamela Stratton
1 reference
Edward W Cowen
1 reference
Douglas B Kuhns
1 reference
12 February 2014
1 reference
1 reference
123
1 reference
15
1 reference
2308-2316
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference